Michael Dishowitz is a life science industry professional with extensive experience in portfolio management and business development. They currently serve as the Manager of Portfolio Decision Sciences at GSK, a position they began in 2023. Prior to this role, they spent five years at the University of Pennsylvania as the Associate Director of PCI Ventures, where they managed a portfolio of startup companies and contributed significantly to their commercialization efforts. Michael holds a Ph.D. in Bioengineering from the University of Pennsylvania and co-founded Skelegen, a biotechnology company focused on bone regeneration.
This person is not in any teams
This person is not in any offices